Abstract
Rituximab Maintenance after First-Line Immunochemotherapy in Mantle Cell Lymphoma: Long-Term Follow-up of the Randomized European MCL Elderly Trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have